Medicare Part D - The product of a broken process

Article Abstract:

Medicare Part D, the new prescription-drug coverage under Medicare launched in the US on January 1, 2006, has achieved few of its original goals. The main problems with the drug benefit are that drug-company and health insurance lobbyists heavily influenced the final legislation passed by Congress, thus focusing mainly on the needs of those industries instead of those of the seniors it should serve.

Political aspects, United States. Congress, Medicare Part D

---

The new Medicare prescription-drug legislation

Article Abstract:

A summary of the prescription drug benefit passed by Congress is presented. Although the program will help many seniors to pay for needed medications, it may have no effect on drug prices. The actual plan does not go into effect until 2006, and the plan may change if the 2004 elections change the party that controls Congress.

---

Bolstering the FDA's drug-safety authority

Article Abstract:

The basic provisions in the Food and Drug Administration Amendments act (FDAAA), drug safety bill which was signed into law on September 27, 2007 are reviewed.

Forecasts, trends, outlooks, Forecasts and trends, Market trend/market analysis, Powers and duties, United States. Food and Drug Administration, Drug approval

Similar abstracts:

• Abstracts: Reaping rewards of loyalty. The return of a forgotten foe: Measles outbreaks spur caution
• Abstracts: The price of a physician practice. Boston's backyard
• Abstracts: Medicare pilot project offers CME for quality improvement . Medicare computers ripe for upgrade
• Abstracts: Low-dose aspirin for the prevention of atherothrombosis. Daily aspirin--only half the answer. Efficacy and safety of low-dose aspirin in polycythemia vera
• Abstracts: Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.